Equifax (EFX) has moved back into focus after announcing new fixed rate notes, along with fresh earnings, updated guidance, and the completion of a large share buyback, giving investors several capital allocation signals to weigh.

Equifax shares have been weak overall, with the year to date share price return down 22.1% and the 1 year total shareholder return down 31.51%, even though the 30 day share price return of 9.3% hints at a short term rebound in sentiment around the recent earnings, guidance, buybacks and new fixed rate notes.

If this mix of earnings, debt issuance and buybacks has you rethinking where growth could come from, it may be a good moment to scan 17 top founder-led companies

After a long stretch of weaker returns and a recent 9.3% bounce, Equifax now sits at a discount to both analyst targets and a cash flow based estimate. The key issue is whether most of the upside still lies ahead or has already been claimed by the latest rally.

Most Popular Narrative: 23.4% Undervalued

Based on the most followed narrative, Equifax’s fair value of $217.67 sits well above the last close at $166.72, putting the recent earnings, guidance and capital deployment moves into sharper focus for valuation driven investors.

Global cloud migration and investments in proprietary technology platforms are now largely complete, enabling margin expansion through operating leverage, efficiency gains, and scalable innovation. This is expected to increase EBITDA and net margins over time. International expansion, especially in underpenetrated markets like Latin America and through the integration of new platforms (Ignite, InterConnect, Data Fabric), is diversifying Equifax's revenue streams and providing additional runway for earnings growth and margin improvement.

Want to understand why this valuation sits well above today’s price? The narrative leans heavily on compounding earnings, thicker margins, and a very specific growth runway. The real story is in how those pieces are modeled together, and what that implies for Equifax’s long term earnings power.

Result: Fair Value of $217.67 (UNDERVALUED)

However, Equifax still faces real pressure from ongoing litigation costs and rising regulatory demands, which could squeeze margins and challenge the earnings path behind that 23.4% discount.

Another View: Equifax Through The P/E Lens

Our DCF work points to Equifax trading well below an estimated future cash flow value of $341.93, yet the P/E picture is very different. On 28.3x earnings, the stock is priced above both peers at 26.9x and a fair ratio of 27.9x, which places more valuation risk on execution. Is the earnings story strong enough to justify paying a higher multiple today?

Next Steps

Mixed signals or a clear message for Equifax investors? With both risks and rewards on the table, now is a good time to review the details and weigh the 4 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Equifax?

If Equifax has sharpened your thinking about value and risk, do not stop here. The next strong idea often comes from widening your opportunity set with intention.

• Target potential value opportunities by scanning 38 high quality undervalued stocks, where solid fundamentals and discounted prices sit side by side.
• Prioritise resilience and capital strength through the solid balance sheet and fundamentals stocks screener (48 results), helping you focus on companies with healthier finances.
• Spot underfollowed potential by running the screener containing 20 high quality undiscovered gems, so you are not the last to notice quality ideas.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.